Fortress Biotech, Inc. SEC filings FBIO
Fortress Biotech, Inc. has 886 filings in SEC EDGAR's recent list, going back to Mar 5, 2008. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 1, 2026 | Sep 30, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2026 | Jun 17, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 17, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Other events
|
Mar 30, 2026 | Mar 30, 2026 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Feb 23, 2026 | Feb 22, 2026 |
| 8-K |
Current report
Other events
|
Jan 13, 2026 | Jan 13, 2026 |
| 424B3 | Prospectus | Dec 18, 2025 | — |
| EFFECT | Filing | Dec 17, 2025 | — |
| CORRESP | Letter to the SEC | Dec 16, 2025 | — |
| S-1 | Registration statement | Dec 16, 2025 | — |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Dec 15, 2025 | Dec 12, 2025 |
| 8-K |
Current report
Other events
|
Dec 15, 2025 | Dec 15, 2025 |
| 8-K |
Current report
Other events
|
Nov 17, 2025 | Nov 14, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| 8-K |
Current report
Other events
|
Oct 1, 2025 | Oct 1, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 424B7 | Filing | Aug 1, 2025 | — |
| 8-K |
Current report
Other events
|
Jul 16, 2025 | Jul 16, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Acquisition or sale of assets
|
Jun 5, 2025 | May 30, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 15, 2025 | May 15, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 28, 2025 | Jun 17, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 16, 2025 | Apr 15, 2025 |
| EFFECT | Filing | Apr 2, 2025 | — |
| EFFECT | Filing | Apr 2, 2025 | — |
| EFFECT | Filing | Apr 2, 2025 | — |
| EFFECT | Filing | Apr 2, 2025 | — |
| POS AM | Filing | Apr 1, 2025 | — |
| POS AM | Filing | Apr 1, 2025 | — |
| POS AM | Filing | Apr 1, 2025 | — |
| POS AM | Filing | Apr 1, 2025 | — |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Material agreement
|
Mar 10, 2025 | Mar 9, 2025 |
| 8-K |
Current report
Other events
|
Jan 16, 2025 | Jan 16, 2025 |
| 8-K |
Current report
Other events
|
Jan 6, 2025 | Jan 6, 2025 |
| 8-K |
Current report
Other events
|
Dec 16, 2024 | Dec 13, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Other events
|
Nov 4, 2024 | Nov 4, 2024 |
| 424B3 | Prospectus | Oct 25, 2024 | — |
| EFFECT | Filing | Oct 7, 2024 | — |
| 424B3 | Prospectus | Oct 7, 2024 | — |
| CORRESP | Letter to the SEC | Oct 2, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 2, 2024 | — |
| S-1 | Registration statement | Sep 27, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Sep 23, 2024 | Sep 19, 2024 |
| 424B5 | Prospectus supplement | Sep 23, 2024 | — |
| 424B5 | Prospectus supplement | Sep 20, 2024 | — |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 424B5 | Prospectus supplement | Aug 2, 2024 | — |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
|
Jul 25, 2024 | Jul 25, 2024 |
| 8-K |
Current report
Material agreement
|
Jul 19, 2024 | Jul 15, 2024 |
| 8-K |
Current report
Other events
|
Jul 5, 2024 | Jul 5, 2024 |
| 8-K |
Current report
Unregistered share sale
|
Jun 28, 2024 | Jun 27, 2024 |
| EFFECT | Filing | Jun 27, 2024 | — |
| 424B3 | Prospectus | Jun 27, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 25, 2024 | Jun 19, 2024 |
| CORRESP | Letter to the SEC | Jun 25, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 24, 2024 | — |
| S-3 | Shelf registration | Jun 20, 2024 | — |
| S-8 | Employee stock plan registration | May 31, 2024 | — |
| S-8 | Employee stock plan registration | May 31, 2024 | — |
| 424B5 | Prospectus supplement | May 31, 2024 | — |
| EFFECT | Filing | May 30, 2024 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 29, 2024 | May 23, 2024 |
| CORRESP | Letter to the SEC | May 29, 2024 | — |
| S-3/A | Form s-3/a | May 29, 2024 | — |
| UPLOAD | Letter from the SEC | May 24, 2024 | — |
| S-3 | Shelf registration | May 17, 2024 | — |
| 10-Q | Quarterly report | May 15, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 15, 2024 | May 15, 2024 |
| DEFA14A | Additional proxy material | Apr 5, 2024 | — |
| DEF 14A | Proxy statement | Apr 5, 2024 | May 23, 2024 |
| 424B3 | Prospectus | Apr 5, 2024 | — |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 26, 2024 | Jan 25, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 3, 2024 | Dec 29, 2023 |
| 424B5 | Prospectus supplement | Jan 3, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 30, 2023 | — |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 14, 2023 | Nov 9, 2023 |
| 424B5 | Prospectus supplement | Nov 13, 2023 | — |
| 424B5 | Prospectus supplement | Nov 9, 2023 | — |
| CORRESP | Letter to the SEC | Oct 26, 2023 | — |
| 8-K |
Current report
Other events
|
Oct 26, 2023 | Oct 24, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Oct 10, 2023 | Oct 9, 2023 |
| S-8 | Employee stock plan registration | Sep 29, 2023 | — |
| S-8 | Employee stock plan registration | Sep 29, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 27, 2023 | — |
| DEFA14A | Additional proxy material | Aug 25, 2023 | — |
| DEF 14A | Proxy statement | Aug 25, 2023 | Oct 9, 2023 |
| PRE 14A | Preliminary proxy statement | Aug 15, 2023 | Oct 9, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Bylaw or fiscal year change
|
Aug 14, 2023 | Aug 10, 2023 |
| CORRESP | Letter to the SEC | Jul 18, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 3, 2023 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 23, 2023 | Jun 21, 2023 |
| 8-K |
Current report
Material agreement, Change to shareholder rights
|
Jun 16, 2023 | Jun 13, 2023 |
| 424B5 | Prospectus supplement | May 26, 2023 | — |
| 8-K |
Current report
Results of operations
|
May 15, 2023 | May 15, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Listing notice
|
May 5, 2023 | May 2, 2023 |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 21, 2023 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| EFFECT | Filing | Apr 13, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Apr 13, 2023 | Apr 10, 2023 |
| CORRESP | Letter to the SEC | Apr 13, 2023 | — |
| S-3/A | Filing | Apr 7, 2023 | — |
| 10-K | Annual report | Mar 31, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2023 | Mar 30, 2023 |
| DEF 14A | Proxy statement | Mar 13, 2023 | Apr 10, 2023 |
| PRE 14A | Preliminary proxy statement | Mar 3, 2023 | Apr 10, 2023 |
| UPLOAD | Letter from the SEC | Feb 15, 2023 | — |
| S-3 | Shelf registration | Feb 10, 2023 | — |
| 8-K |
Current report
Material agreement, Other events
|
Feb 9, 2023 | Feb 7, 2023 |
| 424B5 | Prospectus supplement | Feb 9, 2023 | — |
| 8-K |
Current report
Material agreement, Officer or director change
|
Dec 19, 2022 | Dec 14, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 14, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Listing notice
|
Nov 4, 2022 | Oct 31, 2022 |
| 8-K |
Current report
Officer or director change
|
Oct 28, 2022 | Oct 26, 2022 |
| S-8 | Employee stock plan registration | Oct 21, 2022 | — |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 22, 2022 | Jul 21, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 11, 2022 | Jul 11, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 27, 2022 | Jun 21, 2022 |
| DEFA14A | Additional proxy material | May 17, 2022 | — |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| DEFA14A | Additional proxy material | May 2, 2022 | — |
| DEF 14A | Proxy statement | May 2, 2022 | Jun 21, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2022 | Jun 21, 2022 |
| 10-K | Annual report | Mar 28, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2022 | Mar 28, 2022 |
| 8-K |
Current report
Other events
|
Dec 7, 2021 | Dec 3, 2021 |
| EFFECT | Filing | Dec 1, 2021 | — |
| POS AM | Filing | Nov 24, 2021 | — |
| 8-K |
Current report
Results of operations
|
Nov 15, 2021 | Nov 15, 2021 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| EFFECT | Filing | Nov 4, 2021 | — |
| POS AM | Filing | Nov 3, 2021 | — |
| 8-K |
Current report
Other events
|
Oct 27, 2021 | Oct 27, 2021 |
| CORRESP | Letter to the SEC | Oct 19, 2021 | — |
| POS AM | Filing | Oct 19, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 15, 2021 | — |
| POS AM | Filing | Oct 6, 2021 | — |
| 8-K |
Current report
Other events
|
Oct 6, 2021 | Oct 5, 2021 |
| 8-K |
Current report
Other events
|
Sep 29, 2021 | Sep 28, 2021 |
| 8-K |
Current report
Auditor change, Other events
|
Sep 28, 2021 | Sep 22, 2021 |
| 8-K |
Current report
Auditor change
|
Sep 24, 2021 | Sep 20, 2021 |
| 8-K |
Current report
Other events
|
Aug 27, 2021 | Aug 26, 2021 |
| 10-Q | Quarterly report | Aug 16, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 16, 2021 | Aug 16, 2021 |
| EFFECT | Filing | Jul 30, 2021 | — |
| EFFECT | Filing | Jul 30, 2021 | — |
| 8-K |
Current report
Other events
|
Jul 29, 2021 | Jul 27, 2021 |
| CORRESP | Letter to the SEC | Jul 29, 2021 | — |
| CORRESP | Letter to the SEC | Jul 29, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 29, 2021 | — |
| CORRESP | Letter to the SEC | Jul 28, 2021 | — |
| CORRESP | Letter to the SEC | Jul 28, 2021 | — |
| S-3 | Shelf registration | Jul 23, 2021 | — |
| CORRESP | Letter to the SEC | Jul 23, 2021 | — |
| S-3/A | Filing | Jul 23, 2021 | — |
| 8-K |
Current report
Other events
|
Jul 15, 2021 | Jul 14, 2021 |
| S-3/A | Filing | Jul 2, 2021 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 23, 2021 | Jun 17, 2021 |
| 8-K |
Current report
Other events
|
Jun 17, 2021 | Jun 14, 2021 |
| PX14A6G | Filing | Jun 2, 2021 | — |
| 8-K |
Current report
Results of operations
|
May 17, 2021 | May 16, 2021 |
| 10-Q | Quarterly report | May 17, 2021 | Mar 31, 2021 |
| DEFA14A | Additional proxy material | Apr 30, 2021 | — |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 17, 2021 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2021 | Jun 17, 2021 |
| UPLOAD | Letter from the SEC | Apr 16, 2021 | — |
| 8-K |
Current report
Other events
|
Apr 13, 2021 | Apr 13, 2021 |
| S-3 | Shelf registration | Apr 12, 2021 | — |
| 10-K/A | Amended annual report | Apr 9, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Other events
|
Apr 1, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2021 | Mar 31, 2021 |
| 10-K | Annual report | Mar 31, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Other events
|
Feb 24, 2021 | Feb 24, 2021 |
| EFFECT | Filing | Nov 20, 2020 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- FBIO (Nasdaq), FBIOP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bay Harbor Islands, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1429260
- Former names
- Fortress Biotech, Inc. (until Oct 29, 2026); CORONADO BIOSCIENCES INC (until Apr 27, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.